Literature DB >> 23911709

Clinical factors that predict noncirrhotic portal hypertension in HIV-infected patients: a proposed diagnostic algorithm.

Neil D Parikh1, Valerie Martel-Laferriere, Tatyana Kushner, Kate Childs, Marie-Louise Vachon, Deepti Dronamraju, Chris Taylor, Maria-Isabel Fiel, Thomas Schiano, Mark Nelson, Kosh Agarwal, Douglas T Dieterich.   

Abstract

Noncirrhotic portal hypertension (NCPH) is a rare but important clinical entity in human immunodeficiency virus (HIV) populations. The purpose of this study was to describe the clinical factors associated with the condition in an effort to formulate a diagnostic algorithm for easy and early diagnosis. We performed a multicenter, retrospective case-control study of 34 patients with NCPH and 68 control HIV patients. The study found that thrombocytopenia, splenomegaly, didanosine use, elevated aminotransferases, and an elevated alkaline phosphatase level were all significantly more prevalent in the NCPH cohort. Using these easily available clinical parameters, we developed an algorithm for early diagnosis of NCPH in HIV.

Entities:  

Keywords:  HIV; didanosine; esophageal variceal bleeding; liver disease; noncirrhotic portal hypertension; portal hypertension; splenomegaly; thrombocytopenia

Mesh:

Year:  2013        PMID: 23911709     DOI: 10.1093/infdis/jit412

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

Review 1.  Advances in the management of HIV/HCV coinfection.

Authors:  Mattias Mandorfer; Philipp Schwabl; Sebastian Steiner; Thomas Reiberger; Markus Peck-Radosavljevic
Journal:  Hepatol Int       Date:  2016-01-12       Impact factor: 6.047

2.  [Noncirrhotic portal hypertension in a human immunodeficiency virus (HIV) infected adolescent].

Authors:  Aída de Fátima Thomé Barbosa Gouvêa; Daisy Maria Machado; Suênia Cordeiro de Vasconcelos Beltrão; Fabiana Bononi do Carmo; Regina Helena Guedes Motta Mattar; Regina Célia de Menezes Succi
Journal:  Rev Paul Pediatr       Date:  2015-03-27

3.  Prevalence of significant liver disease in human immunodeficiency virus-infected patients exposed to Didanosine: A cross sectional study.

Authors:  Sarah Logan; Alison Rodger; Laura Maynard-Smith; James O'Beirne; Thomas Fernandez; Filippo Ferro; Colette Smith; Sanjay Bhagani
Journal:  World J Hepatol       Date:  2016-12-28

4.  A Case of Non-Cirrhotic Portal Hypertension Associated With Chronic Didanosine Therapy.

Authors:  Matthew Stotts; Phillip Chisholm; Diana Nurutdinova; Haripriya Maddur
Journal:  ACG Case Rep J       Date:  2015-01-16

5.  Assessment of liver disease by non-invasive methods in perinatally infected Brazilian adolescents and young adults living with Human Immunodeficiency Virus (HIV).

Authors:  Aida de Fátima Thomé Barbosa Gouvêa; Roberto Carvalho Filho; Daisy Maria Machado; Fabiana Bononi do Carmo; Suenia Vasconcelos Beltrão; Laurene Sampaio; Maria Isabel de Moraes-Pinto; Regina Célia de Menezes Succi
Journal:  Braz J Infect Dis       Date:  2021-06-18       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.